Table 1. Infectious complications between after starting bendamustine and the last follow-up.

Patients affected, n (%)	During bendamustine	During observation	During subsequent treatments	Total follow-up
Cytomegalovirus antigenemia
All grades	4 (7)	2 (4)	9 (16)	15 (27)
⩾Grade 3	0 (0)	0 (0)	0 (0)	0 (0)
Cytomegalovirus disease (colitis)
All grades	0 (0)	0 (0)	1 (2)	1 (2)
⩾Grade 3	0 (0)	0 (0)	1 (2)	1 (2)
Pneumocystis pneumonia
All grades	0 (0)	0 (0)	0 (0)	0 (0)
⩾Grade 3	0 (0)	0 (0)	0 (0)	0 (0)
Varicella zoster virus
All grades	0 (0)	0 (0)	2 (4)	2 (4)
⩾Grade 3	0 (0)	0 (0)	1 (2)	1 (2)
Hepatitis B virus reactivation
All grades	1 (2)	0 (0)	1 (2)	2 (4)
⩾Grade3	0 (0)	0 (0)	0 (0)	0 (0)
Other infections
All grades	15 (25)	8 (13)		18 (32)
⩾Grade3	3 (6)	0 (0)		3 (6)